Exane Derivatives’s Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo SPAQ.U Stock Holding History

Exane Derivatives’s Portfolio SPAQ.U Stock Details SPAQ.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-75,000	Closed	-$766K	–	1101
2021 Q4	$766K	Hold	75,000	–	–	0.19%	121
2021 Q3	$764K	Hold	75,000	–	–	0.18%	120
2021 Q2	$753K	Hold	75,000	–	–	0.17%	115
2021 Q1	$752K	Buy	+75,000	New	+$778K	0.22%	105

Exane Derivatives's SPAQ.U Position: Q1 2022 in Review

Exane Derivatives sold out of Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo (SPAQ.U) in Q1 2022, closing a stake of 75,000 shares — an estimated $766K sold.

Exane Derivatives first reported a position in SPAQ.U in Q1 2021 and held it in 4 quarters. The position peaked at $766K in Q4 2021. 0 funds tracked by Wall St. Rank hold SPAQ.U as of Q1 2022.

Exane Derivatives reported no remaining Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo position as of Q1 2022 after selling out during the quarter.
Exane Derivatives sold 75,000 Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo shares in Q1 2022, an estimated $766K.
Exane Derivatives first reported a position in Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo in Q1 2021 and held it in 4 quarters.
Exane Derivatives's Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo position peaked at $766K in Q4 2021.
0 funds tracked by Wall St. Rank held Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.